2024
Prescription of Nicotine Replacement Therapy for Hospitalized Tobacco Users
Nielsen E, Ware E, Heincelman M, Schreiner A, Lenert L, Toll B. Prescription of Nicotine Replacement Therapy for Hospitalized Tobacco Users. Southern Medical Journal 2024, 117: 517-520. PMID: 39094806, DOI: 10.14423/smj.0000000000001719.Peer-Reviewed Original ResearchConceptsNicotine replacement therapyPrescribed nicotine replacement therapyPrescription of nicotine replacement therapyNicotine replacement therapy prescriptionManagement of chronic conditionsHospitalized tobacco usersInitiate health behavior changeHealth behavior changeEmergency department visitsRate of prescriptionTobacco treatmentIncreased readmission ratesChronic conditionsHealth systemDepartment visitsRetrospective cohort studySmoking cessationTobacco usersInpatient admissionsReplacement therapyOutpatient settingCohort studyReadmission ratesSignificantly lower ratesCigarette smokingImplementation of an “opt-out” tobacco treatment program in six hospitals in South Carolina
Cummings K, Talbot V, Roberson A, Bliss A, Likins E, Brownstein N, Stansell S, Adams-Ludd D, Harris B, Louder D, McCutcheon E, Zebian R, Rojewski A, Toll B. Implementation of an “opt-out” tobacco treatment program in six hospitals in South Carolina. BMC Health Services Research 2024, 24: 741. PMID: 38886764, PMCID: PMC11184783, DOI: 10.1186/s12913-024-11205-7.Peer-Reviewed Original ResearchConceptsPost-discharge follow-up callsTobacco treatment programFollow-up callsEnhance careBasic careSmoking statusConsultation visitTobacco treatment specialistStop Smoking ServicesStop smoking medicationsAssess smoking statusResultsSmoking prevalenceSmoking ServicesMedical University of South CarolinaSmoking medicationsIntervention groupQuit ratesTreatment deliveryTreatment specialistsSurveyed patientsDaily smokersHigh caseloadsUniversity of South CarolinaHospital dischargeSouth CarolinaDevelopment of an Electronic Health Record Self-Referral Tool for Lung Cancer Screening: One-Group Posttest Study
Stang G, Tanner N, Hatch A, Godbolt J, Toll B, Rojewski A. Development of an Electronic Health Record Self-Referral Tool for Lung Cancer Screening: One-Group Posttest Study. JMIR Formative Research 2024, 8: e53159. PMID: 38865702, PMCID: PMC11208829, DOI: 10.2196/53159.Peer-Reviewed Original ResearchBarriers and facilitators to involvement in cancer education opportunities among South Carolina cancer care professionals: A cancer training and diversity, equity, and inclusion training needs assessment
Hatch A, Shungu N, Ford M, Toll B. Barriers and facilitators to involvement in cancer education opportunities among South Carolina cancer care professionals: A cancer training and diversity, equity, and inclusion training needs assessment. Journal Of The National Medical Association 2024, 116: 283-291. PMID: 38816266, DOI: 10.1016/j.jnma.2024.05.001.Peer-Reviewed Original ResearchHealthcare professionalsInductive content analysis approachCancer care professionalsNon-Hispanic whitesIdentified educational needsSocial risk factorsAttend educational programsContent analysis approachCases of cancerCancer trainingCancer careCare professionalsPerceived barriersHealth systemMental healthAnalyzed quantitative dataOptimal careTraining needs assessmentTraining needsEducation programsSouth CarolinaQualitative dataBusy schedulesRisk factorsSurvey instrumentVarenicline for E-Cigarette Cessation in Adults: A Preliminary Placebo-Controlled Randomized Trial
Fucito L, Baldassarri S, Baker N, Palmer A, O'Malley S, Carpenter M, Krishnan-Sarin S, Gray K, Toll B. Varenicline for E-Cigarette Cessation in Adults: A Preliminary Placebo-Controlled Randomized Trial. American Journal Of Preventive Medicine 2024, 67: 296-298. PMID: 38752949, PMCID: PMC11260542, DOI: 10.1016/j.amepre.2024.04.007.Peer-Reviewed Original ResearchNicotine e-cigarettes: considerations for healthcare providers
Toll B, Smith T, King B. Nicotine e-cigarettes: considerations for healthcare providers. Nature Medicine 2024, 30: 1513-1514. PMID: 38627561, DOI: 10.1038/s41591-024-02926-7.Peer-Reviewed Original ResearchImplementation, enrollment, and engagement in an opt‐out telehealth pharmacist‐assisted tobacco treatment program for patients seen in oncology outpatient clinics
Cummings K, Toll B, Talbot V, Roberson A, Wilson D, Dunlap M, Ware E, Palmer A, Bliss A, Anokye V, Warren G. Implementation, enrollment, and engagement in an opt‐out telehealth pharmacist‐assisted tobacco treatment program for patients seen in oncology outpatient clinics. Cancer 2024, 130: 2482-2492. PMID: 38546445, PMCID: PMC11214603, DOI: 10.1002/cncr.35291.Peer-Reviewed Original ResearchTobacco treatment programOncology outpatient clinicQuit ratesDelivering smoking cessation treatmentSelf-reported quit ratesOutpatient clinicSmoking cessation counselingHollings Cancer CenterFollow-up surveyNicotine replacement medicationsTreatment programsSmoking cessation treatmentCessation counselingOncology clinicVisit clinicsCessation treatmentSmoking statusTelephone surveyCancer CenterReplacement medicationsRandom sampleAdult patientsFollow-upSmokingPatientsHospitalization as an opportunity to improve lung cancer screening in high-risk patients
Nielsen E, Zhang J, Marsden J, Bays C, Moran W, Mauldin P, Lenert L, Toll B, Schreiner A, Heincelman M. Hospitalization as an opportunity to improve lung cancer screening in high-risk patients. Cancer Epidemiology 2024, 90: 102553. PMID: 38460398, DOI: 10.1016/j.canep.2024.102553.Peer-Reviewed Original ResearchLung cancer screeningLow-dose computed tomographyCancer screeningLDCT completionRates of lung cancer screeningAnnual low-dose computed tomographyImprove lung cancer screeningElectronic health record dataUniversity-based internal medicine clinicLung cancer-related mortalityPrimary care clinicsHealth record dataInternal medicine clinicAssociation of hospitalCox proportional hazards modelsScreening ratesHigh-risk patientsCare clinicsProportional hazards modelRetrospective cohort studyCurrent smokersEligible adultsMedicine clinicReferral programOverall healthShift From Smoking Cigarettes to Vaping Nicotine in Young Adults
Sanford B, Brownstein N, Baker N, Palmer A, Smith T, Rojewski A, Toll B. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Internal Medicine 2024, 184: 106-108. PMID: 37955869, PMCID: PMC10644245, DOI: 10.1001/jamainternmed.2023.5239.Peer-Reviewed Original Research
2023
Is hospitalization a missed opportunity to intervene on tobacco cessation?
Nielsen E, Zhang J, Marsden J, Bays C, Moran W, Mauldin P, Lenert L, Toll B, Schreiner A, Heincelman M. Is hospitalization a missed opportunity to intervene on tobacco cessation? The American Journal Of The Medical Sciences 2023, 367: 89-94. PMID: 38043793, DOI: 10.1016/j.amjms.2023.11.024.Peer-Reviewed Original ResearchTobacco cessationNRT prescriptionCurrent smokersTobacco usePatient-centered medical homeStudy periodNicotine replacement therapy productsRetrospective cohort studyPrimary care physiciansLogistic regression modelsProportion of adultsHealth-related changesAdult patientsCohort studyHospital dischargeMost patientsCare physiciansElevated morbidityMedical homeHospitalizationSmokersPatientsCessationPrescriptionTeachable momentExpectations and Preferences for Digital Cessation Treatment Among Older Adults Who Smoke Cigarettes (Preprint)
Fahey M, Carpenter M, O'Neal R, Pebley K, Schick M, Ware E, Toll B, Dahne J. Expectations and Preferences for Digital Cessation Treatment Among Older Adults Who Smoke Cigarettes (Preprint). Journal Of Medical Internet Research 2023 DOI: 10.2196/52919.Peer-Reviewed Original Research
2013
Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement
Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS, Tobacco and Cancer W. Assessing Tobacco Use by Cancer Patients and Facilitating Cessation: An American Association for Cancer Research Policy Statement. Clinical Cancer Research 2013, 19: 1941-1948. PMID: 23570694, PMCID: PMC5992896, DOI: 10.1158/1078-0432.ccr-13-0666.Peer-Reviewed Original ResearchConceptsTobacco useTobacco cessationCessation interventionsEvidence-based cessation interventionsTreatment-related toxicitySecond primary tumorsTobacco cessation interventionsQuality cancer careQuality of lifeAmerican AssociationCessation assistancePoor outcomeCancer careCancer patientsPrimary tumorOncology settingCancer recurrencePatientsTreatment efficacyTreatment settingsEvidence-based proceduresCancer leadCancerCancer progressionClinical infrastructure
2012
Tobacco Quitlines Need to Assess and Intervene with Callers' Hazardous Drinking
Toll BA, Cummings KM, O'Malley SS, Carlin‐Menter S, McKee SA, Hyland A, Wu R, Hopkins J, Celestino P. Tobacco Quitlines Need to Assess and Intervene with Callers' Hazardous Drinking. Alcohol Clinical And Experimental Research 2012, 36: 1653-1658. PMID: 22703028, PMCID: PMC3436938, DOI: 10.1111/j.1530-0277.2012.01767.x.Peer-Reviewed Original ResearchConceptsSmoking cessation ratesCessation ratesBrief alcohol interventionHazardous drinkingHigh-risk drinkersQuitline callersTobacco quitlineCessation outcomesNIAAA guidelinesAlcohol interventionsLower smoking cessation ratesModerate alcohol consumptionShort-term followQuarter of smokersHazardous drinking patternsHigh rateSmoking cessationDaily smokersModerate drinkersSmoking relapseHazardous drinkersAlcohol consumptionSmokersDrinking patternsQuitline
2010
Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial
Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O’Malley S. Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: A randomized trial. Drug And Alcohol Dependence 2010, 111: 200-206. PMID: 20542391, PMCID: PMC3771701, DOI: 10.1016/j.drugalcdep.2010.04.015.Peer-Reviewed Original ResearchConceptsWeight gainSmoking cessationPoint prevalence smoking abstinence ratePre-specified primary outcomesLow-dose naltrexoneOpen-label therapySmoking abstinence ratesPoint prevalence abstinenceReduced weight gainNaltrexone augmentationPlacebo groupNicotine replacementPrimary outcomeQuit dateAbstinence ratesLabel therapyNicotine patchBehavioral counselingNaltrexoneAbstinent participantsSmokersWeight concernsWeeksCessationLower ratesRandomized Trial: Quitline Specialist Training in Gain-Framed vs Standard-Care Messages for Smoking Cessation
Toll BA, Martino S, Latimer A, Salovey P, O'Malley S, Carlin-Menter S, Hopkins J, Wu R, Celestino P, Cummings KM. Randomized Trial: Quitline Specialist Training in Gain-Framed vs Standard-Care Messages for Smoking Cessation. Journal Of The National Cancer Institute 2010, 102: 96-106. PMID: 20056957, PMCID: PMC2808347, DOI: 10.1093/jnci/djp468.Peer-Reviewed Original ResearchConceptsNew York State Smokers' QuitlineState Smokers' QuitlineSmoking cessationGain-framed messagesNicotine replacement therapySmoking cessation effortsCancer-related mortalitySmoking accountsCessation effortsReplacement therapyEligible callersQuitlineTreatment fidelityCessationCounselingSmokersHigh rateSpecialist trainingLarge proportionSpecialistsTherapyFollowMortalityAbstinenceEarly success
2007
Comparing Gain- and Loss-Framed Messages for Smoking Cessation With Sustained-Release Bupropion: A Randomized Controlled Trial
Toll BA, O'Malley SS, Katulak NA, Wu R, Dubin JA, Latimer A, Meandzija B, George TP, Jatlow P, Cooney JL, Salovey P. Comparing Gain- and Loss-Framed Messages for Smoking Cessation With Sustained-Release Bupropion: A Randomized Controlled Trial. Psychology Of Addictive Behaviors 2007, 21: 534-544. PMID: 18072836, PMCID: PMC2527727, DOI: 10.1037/0893-164x.21.4.534.Peer-Reviewed Original ResearchConceptsSustained-release bupropionSmoking cessationGain-framed messagesLoss-framed messagesTreat analysisControlled TrialsPoint prevalenceClinical trialsContinuous abstinencePrevention behaviorsTreatment completersCessationBupropionExperimental groupTrialsLoss-framed conditionHigher proportionGain-framed conditionParticipantsPrevalenceA preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain
Toll BA, Leary V, Wu R, Salovey P, Meandzija B, O'Malley SS. A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain. Addictive Behaviors 2007, 33: 173-179. PMID: 17587504, PMCID: PMC2488403, DOI: 10.1016/j.addbeh.2007.05.012.Peer-Reviewed Original ResearchConceptsPost-cessation weight gainWeight-concerned smokersPoint prevalence abstinenceWeight gainAbstinent participantsSustained-release bupropion hydrochlorideHigher smoking cessation ratesWeight suppressant effectsOpen-label studyPercentage of patientsSmoking cessation ratesLess weight gainDays of treatmentNaltrexone augmentationAdverse eventsCombination pharmacotherapyPrimary outcomeCessation ratesTreatment regimenCigarette smokersClinical trialsContinuous abstinenceLabel studyPsychosocial interventionsBupropion